Physician profile
Ilya S Johnson
NPI 1154351567
$1,146.21
in general payments reported to CMS, 2019-2025
20 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $81.69 · 2021: $227 · 2022: $197 · 2023: $268 · 2024: $136 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $245.38 | 2020-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Abbvie INC. | $221.32 | 2019-2022 | |
| Myriad Women'S Health, INC. | $136.21 | 2023 | Myrisk |
| Astellas Pharma US INC | $76.73 | 2023-2024 | Veozah |
| Avion Pharmaceuticals | $66.05 | 2021 | |
| Pfizer INC. | $55.37 | 2022-2025 | |
| Myovant Sciences INC. | $39.43 | 2022 | |
| Organon LLC | $37.95 | 2022-2024 | |
| Therapeuticsmd, INC. | $36.41 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.57 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $29.87 | 2025 | |
| Duchesnay USA Incorporated | $26.68 | 2019 | |
| Allergan, INC. | $22.71 | 2019 | |
| Mylan Pharmaceuticals INC. | $21.43 | 2022 | |
| Agile Therapeutics, INC. | $18.22 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $17.88 | 2023 | Axonics |
| Evofem Biosciences, INC. | $17.57 | 2021 | |
| Coopersurgical, INC. | $16.77 | 2025 | Paragard T 380a |
| Kowa Pharmaceuticals America, INC. | $13.85 | 2023 | Seglentis |
| Meditrina | $12.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilya Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.